Protagenic Therapeutics, Inc.
PTIX
$2.15
-$0.10-4.44%
NASDAQ
| 06/30/2025 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 814.30K | 302.70K | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.21M | 321.80K | |||
| Operating Income | -1.21M | -321.80K | |||
| Income Before Tax | -5.06M | -321.80K | |||
| Income Tax Expenses | -- | 2.50K | |||
| Earnings from Continuing Operations | -5.06M | -324.40K | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.06M | -324.40K | |||
| EBIT | -1.21M | -321.80K | |||
| EBITDA | -1.20M | -- | |||
| EPS Basic | -1.37 | -0.06 | |||
| Normalized Basic EPS | -0.85 | -0.04 | |||
| EPS Diluted | -1.37 | -0.06 | |||
| Normalized Diluted EPS | -0.85 | -0.04 | |||
| Average Basic Shares Outstanding | 3.70M | 5.40M | |||
| Average Diluted Shares Outstanding | 3.70M | 5.40M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||